AMETEK, Inc. filings document regulatory disclosures for a NYSE-listed industrial technology company with common stock registered under Section 12(b). Recent Form 8-K reports cover operating results, dividend actions, acquisition-related material events, board appointments, officer transitions and shareholder voting matters.
Proxy materials and annual meeting disclosures address director elections, executive compensation, auditor ratification and other governance matters. AMETEK's filings also describe capital-structure information, material-event exhibits and business reporting for its Electronic Instruments and Electromechanical operations.
AMETEK Inc. chief executive officer and director David A. Zapico reported gifts and a trust sale of company stock. On 12/12/2025, he made a gift of 3,514 shares of AMETEK common stock and a separate gift of 28,390 shares to a family trust. Following these gifts, he directly held 317,051 shares of AMETEK stock.
The family trust, for which Zapico disclaims beneficial ownership, then sold 28,390 shares of AMETEK common stock on the same date at an average price of $201.76 per share, with individual trades ranging from $201.12 to $202.00. After this transaction, the trust held no AMETEK shares, while Zapico continued to report substantial direct ownership.
AMETEK insider plans to sell 28,390 common shares under Rule 144. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,727,682.51. AMETEK had 230,203,873 common shares outstanding, and the planned sale date is listed as 12/12/2025.
The securities to be sold were acquired on 06/04/2001 through the exercise of stock options under a registered plan, in two blocks of 16,219 and 12,171 shares paid in cash. Over the past three months, Dave Zapico reported selling 88,000 AMETEK shares on 11/26/2025 for gross proceeds of $17,300,000.00. The signer represents that they are not aware of undisclosed material adverse information about AMETEK’s current or prospective operations.
AMETEK, Inc. (AME) reported an insider transaction by its Chief Executive Officer and director. On 11/25/2025, the reporting person exercised 88,000 stock options at an exercise price of $63.37 per share, acquiring the same number of AMETEK common shares.
On the same date, the insider sold an aggregate of 88,000 common shares in three transactions: 7,432 shares at a weighted average price of $194.89, 25,815 shares at $195.82, and 54,753 shares at $196.86, with detailed price ranges provided in the notes. After these transactions, the insider directly owned 348,955 shares of common stock, plus 23,982 common stock/ SERP units and 11,080 stock options.
AMETEK, Inc. (AME) received a Form 144 notice covering a planned sale of 88,000 shares of its common stock. The shares are to be sold through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 11/25/2025 and an indicated aggregate market value of $17,282,126.00.
The securities were acquired on 11/25/2025 via an employee stock option exercise using a broker payment for a cashless exercise. As context, the table lists 230,203,873 shares of AMETEK common stock outstanding. This filing is a notice of a proposed sale under Rule 144 rather than an issuer offering.
AMETEK, Inc. (AME) disclosed an insider transaction by its Chief Commercial Officer. On 11/12/2025, the officer sold 2,700 shares of common stock at a price of $200 per share, coded “S” for sale.
Following the transaction, the officer beneficially owned 28,293 shares, reported as direct ownership. No derivative securities were listed in the filing.
AMETEK, Inc. (AME) received a Form 144 notice for a proposed sale of 2,700 common shares. The filing lists an aggregate market value of 540000.00 and names Charles Schwab & Co., Inc. as broker. The shares are slated for sale on or about 11/12/2025 on the NYSE.
The securities were acquired on 02/15/2024 through PSU/RSU equity compensation from AMETEK, Inc., in the same amount of 2,700 shares. As context, AMETEK reported 230203873 shares outstanding in the notice.
AMETEK, Inc. (AME) announced leadership changes in its finance organization. Thomas M. Montgomery, Senior Vice President, Comptroller and Principal Accounting Officer, intends to retire effective January 1, 2026, and will remain a Senior Advisor through 2026. The company elected Robert J. Amodei as Senior Vice President, Controller and Principal Accounting Officer effective January 1, 2026. Amodei, 58, has served as Vice President, Assistant Controller since April 2025 and previously held roles including Vice President, Group Controller for the Electromechanical Group. The company stated there are no arrangements or family relationships related to his selection, and Amodei will be an executive officer. A related press release was furnished as Exhibit 99.1.
AMETEK (AME) insider transaction: The company’s Chief Administrative Officer reported option exercises and an open‑market sale on 10/31/2025. He exercised 14,310 options at $63.37 and 11,980 options at $85.45, then sold 26,290 shares at an average price of $200.0459, per the filing.
Following these transactions, beneficial ownership stood at 40,226 shares held directly, 910 shares held indirectly via a 401(k) plan, and 4,865 shares shown as direct under a SERP-related line item. The sale price range was $200.00 to $200.19, with details available upon request.
AMETEK (AME) filed a Form 144 notice for a proposed sale of 26,290 shares of common stock. The filing lists an aggregate market value of $5,259,208.00, with sales expected around 10/31/2025 on the NYSE. The designated broker is Charles Schwab & Co., Inc.
The shares were acquired via an employee stock option exercise on 10/31/2025 through a broker payment for cashless exercise. Shares outstanding were 230,203,873. Form 144 is a notice of intent under Rule 144 and does not itself constitute a registration or sale.
AMETEK (AME) reported record Q3 2025 results, with net sales of $1,892.6 million, up 10.8% year over year. Operating income reached $488.4 million and diluted EPS rose to $1.60, up 8.8%. Net income was $371.4 million. Orders were a record $1,967.8 million and backlog stood at a record $3,546.3 million.
Segment performance was solid. EIG sales increased to $1,246.3 million, aided by acquisitions, while EMG sales grew to $646.3 million on 12% organic growth. Reported margins reflected acquisition mix and one‑time costs; excluding these effects, margins expanded on Operational Excellence benefits.
Year to date, net sales were $5,402.7 million and operating income was $1,404.8 million. The company closed FARO and Kern, deploying $933.2 million in cash, and ended the quarter with $439.2 million in cash and $2,464.2 million in total debt, including $635.0 million outstanding under the commercial paper program. Free cash flow was $1,144.2 million for the first nine months, and the quarterly dividend was raised to $0.31 per share.